Afuco™ Anti-Frizzled Receptor ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-880)

CAT#: AFC-TAB-880

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human Frizzled receptor. It is a monoclonal antibody designed for the treatment of cancer.

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • Neut, ELISA, IF, IP, FuncS, FC
  • Conjugate
  • Unconjugated
  • Generic Name
  • Vantictumab
  • Related Disease
  • Solid tumors

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • FZD1; frizzled family receptor 1; frizzled (Drosophila) homolog 1, frizzled 1, seven transmembrane spanning receptor, frizzled homolog 1 (Drosophila); frizzled-1; DKFZp564G072; frizzled; Drosophila; homolog of; 1; Wnt receptor
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-880. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Vantictumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Vantictumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Vantictumab"

Anti-Human Frizzled receptor Recombinant Antibody (Vantictumab)
Recombinant human monoclonal antibody expressed in CHO binding to human Frizzled receptor. Vantictumab is a monoclonal antibody designed for the treatment of cancer.
DrugMonitor™ Anti-Vantictumab Antibody (VS-1224-YC1274)
Vantictumab has been used in trials for treating solid tumors and pancreatic cancer, including stage IV pancreatic cancer. The DrugMonitor™ Anti-Vantictumab Antibody (VS-1224-YC1274) is an anti-drug antibody (ADA) against Vantictumab. This drug-based antibody is raised in mice immunized with the Vantictumab. The anti-Vantictumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Vantictumab in samples.

See other products for "Frizzled receptor"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NAB-1026-sdAb Recombinant Anti-Human Frizzled receptor VHH Single Domain Antibody IP, FC, ChiP, Neut Llama VHH
CAT Product Name Application Type
TAB-880 Anti-Human Frizzled receptor Recombinant Antibody (Vantictumab) Inhib, Cyt IgG2 - lambda
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare